Shoulder Pain
Background
Shoulder pain is a prevalent musculoskeletal complaint that can significantly impact an individual's quality of life, daily activities, and ability to work. It arises from the complex anatomical structures of the shoulder joint, including bones, muscles, tendons, ligaments, and bursae. The causes are often multifactorial, ranging from acute injuries and repetitive strain to degenerative conditions that develop over time.
Biological Basis
The shoulder joint's intricate design, which allows for a wide range of motion, also makes it susceptible to various pathologies. Common conditions include shoulder impingement syndrome, where tendons or bursae are compressed, and rotator cuff disease, which involves inflammation or tearing of the tendons surrounding the shoulder joint. [1] Research indicates that chronic pain conditions, including those affecting musculoskeletal regions like the shoulder, are complex heritable traits, meaning genetic factors play a role in an individual's susceptibility. [2] Genome-wide association studies (GWAS) are employed to identify specific genetic variants associated with these conditions. For instance, GWAS have been conducted to pinpoint genetic variants linked to rotator cuff disease and shoulder impingement, with identified loci sometimes showing changes in gene expression following injury. [1] Genes involved in cartilage and bone biology, as well as neurological and inflammatory processes, are often implicated in musculoskeletal pain conditions. [3]
Clinical Relevance
Understanding the underlying causes and biological mechanisms of shoulder pain is crucial for accurate diagnosis, effective treatment, and improved patient outcomes. Clinical relevance extends to distinguishing between different etiologies, such as tendinitis, bursitis, or rotator cuff tears, to guide appropriate interventions. Genetic insights gained from studies can potentially lead to more personalized diagnostic tools and targeted therapeutic strategies, moving beyond symptomatic treatment to address root causes.
Social Importance
Shoulder pain represents a significant public health burden due to its high prevalence and disabling nature. It contributes to substantial healthcare costs, including doctor visits, physical therapy, medication, and surgical procedures. Beyond the economic impact, shoulder pain can severely diminish an individual's quality of life, limiting participation in work, hobbies, and everyday tasks. Ongoing research, particularly in the genetic underpinnings of shoulder pain, is vital for developing preventative measures and more effective treatments to alleviate suffering and reduce the societal burden of this common condition.
Methodological and Statistical Constraints
The interpretation of findings from genome-wide association studies (GWAS) for complex traits like shoulder pain is inherently subject to several methodological and statistical limitations. While large cohorts, such as the UK Biobank used in this research, provide substantial power for identifying common genetic variants, individual variants typically exert only small effect sizes. [2] This means that a considerable portion of the heritable component of shoulder pain, often referred to as "missing heritability," may remain unexplained by the identified common variants, potentially due to the cumulative effect of many small-effect variants, rare variants, or complex epistatic interactions. [4] Furthermore, initial GWAS discoveries often require independent replication in diverse cohorts to confirm their robustness and ensure that observed associations are not inflated due to study-specific biases or population stratification, a step that is crucial for validating findings before clinical translation.
Phenotypic Heterogeneity and Measurement Challenges
The broad clinical definition of "shoulder impingement and rotator cuff disease" presents a significant challenge for precise genetic analysis. These terms encompass a spectrum of conditions ranging from mild tendinopathy to severe, full-thickness rotator cuff tears, which may have distinct underlying pathologies and genetic architectures. Relying on broad diagnostic codes or self-reported data, as is common in large biobanks like the UK Biobank, can introduce phenotypic heterogeneity and potential misclassification among cases and controls. [5] This imprecision in phenotype definition can dilute true genetic signals, making it difficult to identify variants specific to particular sub-types of shoulder pain and hindering the development of targeted therapeutic strategies.
Generalizability and Unaccounted Environmental Factors
The genetic associations identified in this study, primarily utilizing the UK Biobank cohort, are largely based on individuals of European ancestry. [6] This demographic limitation restricts the generalizability of these findings to other ancestral populations, as genetic architectures and allele frequencies can vary significantly across different ethnic groups, potentially leading to differential genetic risk profiles. Beyond genetic factors, shoulder pain and rotator cuff disease are strongly influenced by a multitude of environmental and lifestyle factors, including occupational hazards, physical activity levels, age-related degeneration, and acute trauma. The extent to which these complex gene-environment interactions and other non-genetic confounders were comprehensively captured and accounted for in the analyses can impact the completeness and applicability of the genetic insights.
Variants
Several genetic variants, including those within the FOXP2 and LINC01572 genes, as well as the variant *rs12453010* associated with LINC01982, have been identified in genome-wide association studies (GWAS) for their potential roles in neck or shoulder pain. These genes and their specific single nucleotide polymorphisms (SNPs) shed light on the complex biological pathways that may contribute to chronic pain conditions. The identification of these variants underscores the genetic component influencing susceptibility to musculoskeletal pain. [7]
The FOXP2 gene, a member of the forkhead-box transcription factor family, is particularly notable for its broad regulatory functions, including roles in brain development and function. [7] It is expressed in several brain regions, such as the basal ganglia, locus coeruleus, parabrachial nucleus, and thalamus, all of which are known to be involved in pain modulation. [7] Variants within this gene, including *rs34291892* and *rs2049604*, have been significantly associated with neck or shoulder pain in large cohorts. [7] Furthermore, FOXP2 has been linked to multisite chronic pain, suggesting a broader influence on pain perception and processing in the central nervous system. [7]
Another gene implicated in shoulder pain is LINC01572, a long intergenic non-coding RNA (lincRNA). LincRNAs are crucial regulators of gene expression, influencing processes from chromatin remodeling to transcriptional control, and their dysregulation can contribute to various diseases. The variant *rs62053992* within the LINC01572 locus has shown a significant association with neck or shoulder pain in discovery cohorts. [7] While specific mechanisms are still under investigation, the involvement of lincRNAs like LINC01572 suggests that non-coding genetic elements play an important role in the genetic architecture of pain. [7]
The variant *rs12453010* is associated with the LINC01982 gene, another long intergenic non-coding RNA, and was identified in a GWAS for neck or shoulder pain. This SNP, located in an intergenic area on chromosome 17, exhibited the most significant association in the initial discovery phase of a large-scale study. [7] Although replication efforts for this specific locus yielded weaker support, its strong initial signal highlights its potential importance in the genetic predisposition to shoulder pain. The precise way *rs12453010* influences the function of LINC01982 or related pathways in the context of pain modulation warrants further investigation. [7]
Key Variants
| RS ID | Gene | Related Traits |
|---|---|---|
| rs12453010 | CA10 - LINC01982 | gastroesophageal reflux disease educational attainment shoulder pain |
| rs34291892 | FOXP2 | shoulder pain |
| rs2049604 | FOXP2 | shoulder pain health study participation self reported educational attainment aggressive behavior quality, ADHD symptom measurement post-traumatic stress disorder |
| rs62053992 | LINC01572 | shoulder pain intelligence body height sexual dimorphism measurement |
Conceptualizing and Defining Shoulder Pain
Shoulder pain is generally understood as discomfort arising from the shoulder region, often considered a single entity with neck pain in many epidemiological studies due to the close anatomical relationship between the neck and shoulder, and the common difficulty individuals experience in accurately differentiating pain in these areas. [7] Lesions or pathologies in one region can frequently manifest as pain in the other, further supporting their combined consideration in research. [7] From a conceptual framework, shoulder pain, particularly when combined with neck pain, aligns with the biopsychosocial model, acknowledging that its etiology and prognosis are influenced by a complex interplay of biological, psychological, and social factors, rather than purely mechanical causes. [7]
Operational definitions for shoulder pain vary across research cohorts, reflecting diverse measurement approaches. In the UK Biobank discovery cohort, cases were defined as participants reporting activity-limiting neck or shoulder pain within the past month, with controls indicating no pain across any listed regions. [7] This definition was broad, as it did not document severity, frequency, or exact location of the pain. [7] Replication cohorts employed similar self-reported criteria; the GS:SFHS cohort defined cases as those with neck or shoulder pain lasting more than three months, while TwinsUK identified cases as individuals reporting neck or shoulder pain in the past three months. [7] These definitions establish a categorical approach to identifying individuals experiencing shoulder pain for research purposes.
Classification Systems and Subtypes
Classification of shoulder pain broadly includes general categories of musculoskeletal discomfort, but specific subtypes are recognized based on underlying pathology. Shoulder impingement syndrome (SIS) is a notable example, characterized by a distinct pathophysiological mechanism involving mechanical conflicts between various shoulder joint structures. [8] Key characteristics contributing to SIS include rotator cuff muscle weakness, tightness, and the degeneration or inflammation of tendons and bursa, alongside dysfunctional glenohumeral and scapulothoracic kinematics. [8] While general shoulder pain is often treated as a broad category in large-scale epidemiological and genetic studies, conditions like SIS represent more specific nosological entities within the spectrum of shoulder disorders, allowing for more targeted clinical and research investigations into their unique genetic and environmental contributors.
Severity gradations for shoulder pain are often implied by its impact on daily life, such as "interfering with usual activities," as used in some research criteria. [7] However, detailed dimensional assessments of pain intensity or functional limitation are not always uniformly documented across all studies, particularly in large cohorts relying on self-reported questionnaires. [7] This can lead to a categorical classification of "pain present" versus "pain absent" rather than a nuanced dimensional understanding of the pain experience. Other musculoskeletal conditions like low back pain are sometimes referenced to provide comparative contexts for prevalence, recovery rates, and genetic influences, highlighting the broader classification of musculoskeletal disorders within which shoulder pain resides. [7]
Terminology and Diagnostic Criteria
The primary terminology used in many studies, especially large-scale genetic investigations, is "neck or shoulder pain," often treated as a unified phenotype due to the anatomical and symptomatic overlap. [7] This composite term reflects a practical approach for epidemiological assessment, acknowledging the challenge of precise self-localization of pain. Beyond this general nomenclature, specific related concepts include "shoulder impingement syndrome" (SIS), which describes a particular set of symptoms and pathophysiological changes in the shoulder joint. [8] Other terms related to the pathology of SIS encompass "rotator cuff muscle weakness," "tendon or bursa inflammation," and "dysfunctional glenohumeral and scapulothoracic kinematics," which provide more granular descriptions of the underlying issues. [8]
Diagnostic and measurement criteria for shoulder pain largely rely on self-report questionnaires in research settings. Clinical criteria often involve a combination of patient-reported symptoms, physical examination, and imaging, but these are not always standardized or available across large cohorts. For research, the criteria for identifying cases typically include affirmative responses to questions about pain presence, location, and duration. For instance, participants in the UK Biobank were asked if they experienced "Neck or shoulder pain" in the last month that "interfered with usual activities". [7] Replication cohorts used similar self-reported inquiries regarding pain in the "neck or shoulders" over the "past three months" or "more than 3 months". [7] While genetic variants like rs2049604 in FOXP2 and rs62053992 in LINC01572 have been associated with neck or shoulder pain, and rs750968, rs754832, and rs1873119 with SIS, these are genetic markers rather than direct diagnostic biomarkers or thresholds for clinical diagnosis. [8]
Presentation and Subjective Experience
Shoulder pain typically manifests as discomfort or pain in the neck or shoulder region, which can be constant or intermittent . Understanding these specific genetic predispositions is crucial for elucidating the etiology of common shoulder pathologies.
Polygenic Risk and Shared Genetic Basis with Musculoskeletal Pain
Chronic pain disorders, including various forms of musculoskeletal pain such as neck/shoulder pain, are recognized as complex heritable traits, meaning they are influenced by multiple genes working in concert. [2] GWAS have been instrumental in identifying susceptibility genes for these conditions, revealing a shared genetic architecture across different pain phenotypes. For instance, genes implicated in intervertebral disc disorder (IDD) and dorsalgia, such as CHST3, SLC13A1, SOX5, and GSDMC, are involved in cartilage and bone biology, suggesting broader genetic influences on connective tissue health that could extend to shoulder joints. [3] Furthermore, variants in SMAD3, a gene critical to the TGFB pathway, are linked to connective tissue disorders like aneurysms-osteoarthritis syndrome and Loeys-Dietz Syndrome, and also associate with hip, knee, and spinal osteoarthritis, indicating a systemic genetic predisposition to musculoskeletal pathology. [3]
Comorbidities and Age-Related Contributors
The development and persistence of shoulder pain can be significantly influenced by comorbidities and age-related degenerative processes. Osteoarthritis, a common age-related condition, shows genetic correlations with various musculoskeletal pain phenotypes, including intervertebral disc disorder and dorsalgia, suggesting shared underlying genetic vulnerabilities that could predispose individuals to shoulder joint degeneration. [3] The presence of rare missense and loss-of-function mutations in SMAD3, which are associated with connective tissue disorders, highlights how systemic conditions affecting collagen and extracellular matrix integrity can contribute to musculoskeletal fragility and pain throughout the body, including the shoulder. [3] Age-related changes, such as disc degeneration in the spine, are also genetically linked to chronic back pain, implying that similar degenerative pathways may contribute to the increasing prevalence of shoulder pain with advancing age. [6]
Biological Background of Shoulder Pain
Shoulder pain, encompassing conditions like Shoulder Impingement Syndrome (SIS), represents a significant health challenge characterized by diverse biological underpinnings. It is a common musculoskeletal disorder with complex genetic and pathophysiological mechanisms that impact daily life and impose substantial societal burdens. [8] Understanding the biological basis of shoulder pain involves exploring the anatomical structures, cellular and molecular pathways, genetic predispositions, and systemic influences that contribute to its development and persistence.
Anatomical and Pathophysiological Foundations of Shoulder Pain
Shoulder pain, particularly Shoulder Impingement Syndrome, arises from a complex interplay of anatomical and functional disruptions within the shoulder joint. [8] Key symptoms include localized pain, stiffness, and weakness in the rotator cuff muscles, frequently accompanied by inflammation and degeneration of the tendons or bursa. [8] The primary pathophysiological mechanism often involves mechanical conflicts between different shoulder joint structures, resulting from dysfunctional glenohumeral and scapulothoracic kinematics during movement. [8]
The broad impact of shoulder pain extends beyond individual discomfort, contributing significantly to global health burdens and economic strain . [9], [10] Epidemiological studies highlight that neck and shoulder pain are often considered a single entity, given the difficulty in clinically differentiating pain in these interconnected regions and the potential for pain to radiate between them . [7], [11] This combined condition was ranked among the top causes of overall burden and disability globally in 2010 . [9], [10] Furthermore, recovery rates for non-traumatic complaints in the arm, neck, and shoulder can be low, with a significant proportion of individuals not achieving complete recovery after several months . [5], [12]
Cellular and Molecular Pathways of Inflammation and Tissue Remodeling
At the cellular and molecular levels, shoulder pain involves intricate processes leading to tissue degeneration and inflammation. The gene ANXA1 (Annexin A1), located on chromosome 9, has been identified as a significant risk locus for Shoulder Impingement Syndrome. [8] ANXA1 is involved in several critical cellular functions, including the regulation of neutrophil clearance by macrophages in the bone marrow and influencing the proliferation and osteogenic differentiation of mesenchymal stem cells . [13], [14] These roles suggest that ANXA1 contributes to the body's inflammatory response and tissue repair mechanisms, which are crucial for maintaining shoulder joint health.
Disruptions in other molecular pathways also contribute to shoulder pathology. Chondrocyte apoptosis, the programmed cell death of cartilage cells, is influenced by expression quantitative trait loci (eQTLs) that regulate apoptosis pathway expression. [15] Metabolic processes such as mitochondrial oxidative phosphorylation are essential regulators of nitric oxide's effects on chondrocyte matrix synthesis and mineralization, highlighting their importance in cartilage integrity. [16] Furthermore, gene set enrichment analyses for SIS have revealed the involvement of the KEGG_CALCIUM_SIGNALING_PATHWAY, pointing to the critical role of calcium ion regulation in the cellular mechanisms underlying this condition. [8] Hypoxia, or oxygen deprivation, has also been implicated in the pathogenesis of osteochondropathy, affecting bone and cartilage health. [15]
Genetic Influences and Regulatory Mechanisms
Genetic factors play a significant role in an individual's susceptibility to shoulder pain. Twin studies have demonstrated a heritable component for neck pain, noting that while this genetic influence may diminish with age, it can account for a substantial proportion of the variance in pain liability in younger individuals, such as adolescents . [17], [18], [19] Genome-Wide Association Studies (GWAS) have advanced our understanding by identifying specific genetic loci associated with neck or shoulder pain, including variants like rs2049604 in the FOXP2 gene and rs62053992 in the LINC01572 gene. [7] In gene-based association analyses, FOXP2 emerged as a highly significant gene associated with neck or shoulder pain. [7]
For Shoulder Impingement Syndrome, GWAS have pinpointed several risk loci, notably rs750968 and rs754832, which are located near the ANXA1 gene. [8] Variations within ANXA1 may influence an individual's predisposition to SIS by altering inflammatory and tissue remodeling processes, which are vital for maintaining joint health. Overall, SNP-based heritability estimates for chronic musculoskeletal pain, including conditions affecting the neck and shoulder, range from 2% to 16% depending on the estimation method, emphasizing the inherent genetic contribution to these complex pain conditions. [2]
Systemic and Neurological Aspects of Pain Perception
The experience of shoulder pain involves intricate systemic and neurological processes that extend beyond localized tissue damage. Pain perception is modulated by complex signaling cascades within the central nervous system, where ionotropic and metabotropic receptors, alongside key protein kinases such as protein kinase A (PKA), protein kinase C (PKC), and Src, contribute to neural sensitization. [20] These molecular components are critical for activating downstream pathways, including ERK, and phosphorylating cAMP response element-binding protein in dorsal horn neurons, ultimately leading to central sensitization, a state of heightened pain sensitivity. [20]
Furthermore, gene set enrichment analyses for SIS have highlighted the involvement of the KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION pathway, underscoring the importance of neurotransmission and receptor binding in the pathophysiology of shoulder pain. [8] The overlapping nature of neck and shoulder pain, often considered a single clinical entity, suggests shared neurological pathways and systemic responses to injury or inflammation . [7], [11] The development and persistence of shoulder pain are also influenced by a biopsychosocial model, integrating biological vulnerabilities with factors such as age, sex, body mass index, and occupational stressors, indicating a broad systemic and environmental influence on pain outcomes . [7], [21]
Inflammation and Immune Modulation
Inflammatory processes are central to the pathogenesis of shoulder pain, particularly in conditions like Shoulder Impingement Syndrome (SIS), where degeneration and inflammation of tendons or bursa are observed. [8] A key mediator in this context is ANXA1 (Annexin A1), a membrane-localized protein that inhibits phospholipase A2 and possesses significant anti-inflammatory activity. [8] Dysregulation of ANXA1 can lead to uncontrolled inflammation, contributing to tissue damage and pain signaling. Furthermore, studies indicate the involvement of signaling pathways in macrophages, which are critical immune cells that orchestrate inflammatory responses and tissue repair, highlighting the intricate interplay between the immune system and localized tissue pathology. [22]
Cellular Stress Responses and Metabolic Homeostasis
Cellular stress pathways, such as those activated by hypoxia, are implicated in the development of musculoskeletal conditions that can contribute to shoulder pain. The "MANALO_HYPOXIA_UP" pathway, identified as significant in shoulder impingement syndrome [8] underscores how insufficient oxygen supply can lead to cellular dysfunction and tissue damage, particularly in areas with compromised blood flow. This metabolic stress can alter energy metabolism and cellular biosynthesis, driving cells towards catabolic states and potentially contributing to tissue degeneration. Additionally, pathways related to the "RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS," also identified as significant [8] suggest a role for oxidative stress and lipid metabolism dysregulation in the cellular environment of the affected shoulder.
Neural Signaling and Pain Processing
The transmission and perception of pain in the shoulder involve complex neural signaling pathways. The "KEGG_CALCIUM_SIGNALING_PATHWAY" and "KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION" pathways are significantly associated with shoulder impingement syndrome [8] indicating the importance of receptor activation and subsequent intracellular signaling cascades in pain modulation. For instance, protein kinase C (PKC) plays a crucial role in central sensitization, contributing to enhanced pain perception by mediating C-fiber-induced ERK activation and cAMP response element-binding protein phosphorylation in dorsal horn neurons. [23] This highlights how molecular interactions within neurons contribute to the broader neurological network that processes and amplifies pain signals.
Tissue Integrity and Repair Dynamics
The integrity of shoulder tissues, including tendons and cartilage, is maintained through precise regulatory mechanisms involving cell survival and repair. Degeneration of tendons or bursa is a recognized feature of shoulder pain [8] suggesting a failure in tissue maintenance or repair processes. The apoptosis pathway, which regulates programmed cell death, is critical, as its dysregulation can contribute to conditions like chondrocyte apoptosis in osteochondropathy. [24] Additionally, the "IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN" pathway [8] suggests that alterations in stem cell differentiation and function, which are vital for tissue regeneration and repair, may play a role in the chronic nature or progression of shoulder disorders.
Genetic Regulation and Pathway Dysregulation
Genetic factors significantly influence susceptibility to shoulder pain, with specific gene loci and pathways being identified through genome-wide association studies (GWAS). Variants near the ANXA1 gene, such as rs754832 and rs750968, are associated with shoulder impingement syndrome [8] indicating a genetic predisposition that can impact inflammatory control. Other genetic loci, like those in the FOXP2 and LINC01572 genes, have also been linked to neck or shoulder pain. [7] These genetic variations can lead to pathway dysregulation, where altered gene expression, potentially mediated by expression Quantitative Trait Loci (eQTLs), affects protein function and downstream signaling, ultimately contributing to the development and persistence of shoulder pain. [24]
Global Burden and Epidemiological Patterns
Neck or shoulder pain represents a significant public health challenge with substantial global impact. Epidemiological studies indicate a prevalence of 5–8% for neck pain and 13% for shoulder pain individually. [7] When considered as a combined entity, which is common given the difficulty in differentiating pain in these areas, the societal burden is considerable. [7] The Global Burden of Disease Study 2010 ranked neck or shoulder pain 21st among 291 conditions in terms of overall burden and 4th in terms of overall disability. [9] Updated findings from the Global Burden of Disease Study 2016 further underscore this, identifying neck pain as a top five cause of years lived with disability (YLD) in high-income and high-middle-income countries. [7] This consistent ranking highlights the persistent and widespread nature of neck or shoulder pain, affecting daily activities and leading to significant disability across diverse populations. [21]
Demographic and Socioeconomic Correlates
Population studies reveal several demographic and socioeconomic factors consistently associated with neck or shoulder pain. Older age and higher body mass index (BMI) are frequently identified risk factors. [7] While some research suggests females are more prone to neck or shoulder pain, the UK Biobank cohort, a large-scale population study, observed a higher likelihood of reporting neck or shoulder pain among males. [7] This finding is potentially linked to males being more frequently engaged in strenuous occupations. [7] Furthermore, socioeconomic indicators such as a younger age at first child, lower rates of college completion, and fewer years of schooling are inversely correlated with the likelihood of reporting neck or shoulder pain, pointing to the influence of lifestyle, deprivation levels, and occupational factors. [7] Other associated factors include previous injury and comorbidities like diabetes mellitus, aligning with a biopsychosocial model of pain. [7] Studies in working populations also suggest that mechanical and psychosocial exposures at work can influence the incidence of neck and shoulder pain. [25]
Large-Scale Cohort Studies and Methodological Approaches
Large-scale cohort studies, particularly biobank initiatives, have been instrumental in advancing the understanding of neck or shoulder pain. The UK Biobank, a discovery cohort comprising over 200,000 participants for neck or shoulder pain analyses, defines cases as individuals reporting activity-limiting pain in the neck or shoulder in the preceding month, with controls reporting no pain. [7] This broad phenotyping, while allowing for large sample sizes, means that specific details regarding pain severity, frequency, or exact location are often not documented. [7] Replication efforts are crucial for validating findings, with studies utilizing cohorts such as Generation Scotland: Scottish Family Health Study (GS:SFHS) and TwinsUK, which employ slightly different self-reported pain definitions over a three-month period. [7]
These studies underscore methodological considerations, including the impact of varying case and control definitions across cohorts on generalizability. [7] For instance, the UK Biobank's reliance on hospital-coded diagnoses for some conditions may capture only more severe cases, while primary care records might be overly sensitive. [26] Additionally, analyses from the UK Biobank and other large cohorts frequently focus on populations of European ancestry, necessitating further research to determine if findings replicate across other ethnic groups. [26] The UK Biobank itself primarily includes participants aged 40 to 69 at recruitment, which, while covering a common incidence range for conditions like frozen shoulder, may not fully represent the entire age spectrum of shoulder pain prevalence. [26] Despite these limitations, the scale and depth of data in these biobanks facilitate detailed epidemiological analyses and genetic correlation studies, such as the identification of shared genetic factors across various chronic musculoskeletal pain conditions. [2]
Frequently Asked Questions About Shoulder Pain
These questions address the most important and specific aspects of shoulder pain based on current genetic research.
1. Why do I get shoulder pain when my friend lifts heavy too?
Your susceptibility to shoulder pain, even with similar activities, can be influenced by your genetics. Research shows that inherited factors play a role in conditions like rotator cuff disease and impingement. Specific genetic variants can affect the strength and repair of your tendons and cartilage, making some individuals more prone to injury and pain than others.
2. Will my kids inherit my tendency for bad shoulders?
Yes, there's a chance your children could inherit a predisposition to shoulder pain. Chronic musculoskeletal pain conditions, including those affecting the shoulder, are considered complex heritable traits. While not a guarantee, certain genetic factors can increase their susceptibility to developing similar issues later in life.
3. Does my shoulder pain just happen because I'm getting older?
While age-related degeneration is a strong factor, your genetics also play a role in how susceptible your shoulder structures are to wear and tear. Genes involved in cartilage and bone biology can influence how your shoulder tissues maintain themselves over time, affecting your personal risk for conditions like rotator cuff disease as you age.
4. Why does my shoulder injury heal slower than other people's?
Genetic factors can influence your body's healing processes and inflammatory responses. Some genetic variants, for example in genes like FOXP2 or LINC01572, might affect how quickly your tissues repair or how effectively your body manages inflammation after an injury, potentially leading to a slower recovery compared to others.
5. Can exercise prevent my inherited shoulder problems?
Exercise and lifestyle are crucial, but genetics can influence your baseline susceptibility. While staying active can strengthen your shoulder and reduce risk, if you have a strong genetic predisposition, you might still be more prone to issues despite your best efforts. It's about managing your personal risk factors.
6. Could a special test tell me the real cause of my shoulder pain?
Genetic insights are advancing, and future personalized diagnostic tools are a goal. While not routine yet, research like genome-wide association studies is identifying specific genetic variants linked to shoulder pain conditions. In the future, such tests might help predict your risk or guide more targeted treatments, moving beyond just symptoms.
7. Does my family's ethnic background change my shoulder pain risk?
Yes, ancestral background can influence genetic risk profiles for conditions like shoulder pain. Most current genetic studies are based on individuals of European ancestry, meaning genetic architectures and allele frequencies can differ significantly in other ethnic groups. This highlights the importance of diverse research for broader applicability.
8. Is my chronic shoulder pain linked to other body aches I get?
Possibly. Research suggests that chronic musculoskeletal pain conditions, which include shoulder pain, can share common genetic factors. This means that if you have a genetic predisposition to chronic pain in your shoulder, you might also have an increased susceptibility to pain in other areas of your body due to these shared genetic influences.
9. Why is my shoulder pain so severe, unlike my friend's mild tendinitis?
The severity and specific type of shoulder pain you experience can be influenced by your unique genetic makeup. "Shoulder impingement and rotator cuff disease" encompass a range of conditions, and your individual genetic variants can affect the underlying pathology, leading to different levels of pain or distinct disease subtypes compared to others.
10. Does my job's repetitive motions affect me more because of my genes?
Yes, environmental factors like repetitive motions interact with your genetic predisposition. If you carry genetic variants that make your tendons or cartilage more vulnerable, occupational hazards or repetitive strain could have a greater impact on you, increasing your personal risk for developing shoulder pain compared to someone with a different genetic profile.
This FAQ was automatically generated based on current genetic research and may be updated as new information becomes available.
Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice. Always consult with a healthcare provider for personalized medical guidance.
References
[1] Kim, S.K., et al. "A genome-wide association study for shoulder impingement and rotator cuff disease." J Shoulder Elbow Surg, vol. 30, no. 9, Sep. 2021, pp. 2134-2145.
[2] Tsepilov, Y. A., Aulchenko, Y. S., & Zhernakova, A. (2020). Analysis of genetically independent phenotypes identifies shared genetic factors associated with chronic musculoskeletal pain conditions. Communications Biology, 3(1), 1-10.
[3] Bjornsdottir, G., et al. "Rare SLC13A1 variants associate with intervertebral disc disorder highlighting role of sulfate in disc pathology." Nat Commun, vol. 13, no. 1, 2 Feb. 2022, p. 660.
[4] Freidin, M.B., et al. "Insight into the genetic architecture of back pain and its risk factors from a study of 509,000 individuals." Pain, vol. 160, no. 4, Apr. 2019, pp. 891-900.
[5] Feleus, A. et al. "Prognostic indicators for non-recovery of non-traumatic complaints at arm, neck and shoulder in general practice–6 months follow-up." Rheumatology (Oxford), vol. 46, 2007, pp. 1616–1622.
[6] Suri, P., et al. "Genome-wide meta-analysis of 158,000 individuals of European ancestry identifies three loci associated with chronic back pain." PLoS Genet, vol. 14, no. 9, 27 Sep. 2018, p. e1007721.
[7] Meng W, et al. "A genome-wide association study finds genetic variants associated with neck or shoulder pain in UK Biobank." Hum Mol Genet, 2020.
[8] Cheng B, et al. "Genome-Wide Association Analysis Identified ANXA1 Associated with Shoulder Impingement Syndrome in UK Biobank Samples." G3 (Bethesda), 2020.
[9] Hoy, D., March, L., Woolf, A., Blyth, F., Brooks, P., Smith, E., ... & Murray, C. (2014). The global burden of neck pain: estimates from the global burden of disease 2010 study. Annals of the Rheumatic Diseases, 73(7), 1309-1315.
[10] March, L., Smith, E. U., Hoy, D. G., Cross, M. J., Sanchez-Riera, L., Blyth, F., ... & Woolf, A. D. (2014). Burden of disability due to musculoskeletal (MSK) disorders. Best Practice & Research Clinical Rheumatology, 28(3), 353-366.
[11] Pasanen, K., Kokko, S., Alanko, L., Heinonen, O. J., Korpelainen, R., Savonen, K., ... & Kannas, L. (2016). Low back and neck and shoulder pain in members and non-members of adolescents’ sports clubs: the Finnish Health promoting sports Club (FHPSC) study. BMC Musculoskeletal Disorders, 17(1), 263.
[12] Vos, C. J., Verhagen, A. P., Passchier, J., and Koes, B. W. "Clinical course and prognostic factors in acute neck pain: an inception cohort study in general practice." Pain Med., vol. 9, 2008.
[13] Dalli, J., C. P. Jones, D. M. Cavalcanti, S. H. Farsky, M. Perretti, S. M. Rankin. "Annexin A1 regulates neutrophil clearance by macrophages in the mouse bone marrow." FASEB J., vol. 26, 2012, pp. 387-396.
[14] Liang, B. W., X. Y. Pan, J. M. Zhao, and G. Q. Yin. "Effects of silencing annexin A1 gene on proliferation and osteogenic differentiation of rabbit bone marrow mesenchymal stem cells." Chinese Journal of Tissue Engineering Research, vol. 16, 2012, pp. 3421.
[15] Zhang, F., et al. "Genome-wide gene expression analysis suggests an important role of hypoxia in the pathogenesis of endemic osteochondropathy Kashin-Beck disease." PLoS One, vol. 6, no. 8, 2011, p. e22983.
[16] Johnson, K., A. Jung, A. Murphy, A. Andreyev, J. Dykens et al. "Mitochondrial oxidative phosphorylation is a downstream regulator of nitric oxide effects on chondrocyte matrix synthesis and mineralization." Arthritis Rheum., vol. 43, no. 7, 2000, pp. 1560-1570.
[17] Fejer, R., Hartvigsen, J., and Kyvik, K. O. "Heritability of neck pain: a population-based study of 33,794 Danish twins." Rheumatology (Oxford), vol. 45, 2006, pp. 589–594.
[18] MacGregor, A. J., Andrew, T., Sambrook, P. N., & Spector, T. D. (2004). Structural, psychological, and genetic influences on low back and neck pain: a study of adult female twins. Arthritis & Rheumatism, 51(2), 160-167.
[19] Hartvigsen, J., Petersen, H. C., Pedersen, H. C., Frederiksen, H., and Christensen, K. "Small effect of genetic factors on neck pain in old age: a study of 2,108 Danish twins 70 years of age and older." Spine (Phila Pa 1976), vol. 30, 2005, pp. 206–208.
[20] Kawasaki, Y., Kohno, T., Zhuang, ZY., Brenner, GJ., Wang, H., Van Der Meer, C. et al. "Ionotropic and metabotropic receptors, protein kinase A, protein kinase C, and Src contribute to C-fiber-induced ERK activation and cAMP response element-binding protein phosphorylation in dorsal horn neurons, leading to central sensitization." J Neurosci, vol. 24, 2004, pp. 8310–8321.
[21] Wright, A. R., Shi, X. A., Busby-Whitehead, J., Jordan, J. M., & Nelson, A. E. (2009). The prevalence of neck and shoulder symptoms and associations with comorbidities and disability: the Johnston County osteoarthritis project. Myopain, 23(3-4), 163-176.
[22] Zhou, Q., and S. Amar. "Identification of signaling pathways in macrophage exposed to Porphyromonas gingivalis or to its purified cell wall components." Journal of Immunology, vol. 179, no. 11, 2007, pp. 7777–7790.
[23] Warner, S.C., et al. "Genome-wide association scan of neuropathic pain symptoms post total joint replacement highlights a variant in the protein-kinase C gene." European Journal of Human Genetics, vol. 25, no. 3, 2017, pp. 334–340.
[24] Zhang, F., et al. "Trans-omics pathway analysis suggests that eQTLs contribute to chondrocyte apoptosis of Kashin-Beck disease through regulating apoptosis pathway expression." Gene, vol. 553, no. 1, 2014, pp. 166–169.
[25] Ostergren, P. O., Hanson, B. S., Balogh, I., Ektor-Andersen, J., Isacsson, A., Orbaek, P., ... & Malmö Shoulder Neck Study Group. (2005). Incidence of shoulder and neck pain in a working population: effect modification between mechanical and psychosocial exposures at work? Results from a one year follow up of the Malmö shoulder and neck study cohort. Journal of Epidemiology & Community Health, 59(9), 721-728.
[26] Green, H. D., Green, J. R., Davies, A. H., & Deloukas, P. (2021). A genome-wide association study identifies 5 loci associated with frozen shoulder and implicates diabetes as a causal risk factor. PLoS Genetics, 17(6), e1009586.